Plunkett Research Online: Lisata Therapeutics Inc

LISATA THERAPEUTICS INC (LSTA:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co.....



Lisata Therapeutics Inc
Ticker: LSTA
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 212-584-4180
Fax: 646-514-7787
Address: 110 Allen Road
2nd Floor
Basking Ridge, NJ 07920 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Stem Cell Processing
Contract Research & Development
Drug Discovery & Development
Contacts Description
David MazzoCEO/Director/President
James NiscoCFO/Chief Accounting Officer/Senior VP, Divisional
See More
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co.....See More See More

Auditor: Grant Thornton LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202420232022202120202019
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
VSEL
Progenitor Cell Therapy LLC
Amorcyte LLC
NameTitleSalary (US$)Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: